The Global Single-cell multi-omics market fuelled the market growth owing to advancement in technology and spurred in chronic diseases
The Global single-cell multi-omics market will emerge with a significant CAGR in the forecast period from 2020–2027. A variety of omics single-cell technologies have been allowing researchers to understand the status of every single cell more precisely, especially for tumors. The research on the occurrence and development of embryos, embryonic development, and complex tissues is more in-depth.
The rapid development of single-cell analysis technology is due to analytical tools, such as cell separation, microfluidics, single-cell sequencing, and so on. The application of single-cell analysis has involved many fields, including basic research applications, such as cancer, immunology, neurology, stem cells, etc., clinical applications, such as non-invasive prenatal diagnosis, in vitro fertilization, and circulating tumor cells (CTCs).
Moreover, rising non-invasive instruments, increasing demand for personalized medicines, and enhancing infrastructure for testing drugs are fueling the healthcare industry. Additionally, the market demand for single-cell multi-omics has emerged owing to the propelling chronic diseases such as cancer, tumors, etc.
Product Overview in the Global single cell multi omics Market
Based on the product, the global single-cell multi-omics market segmented into Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics, Single Cell Metabolomics. The single-cell transcriptomics segment has captured the highest market value in the global single-cell multi-omics market in the forecast period from 2020–2027. Transcriptome sequencing can detect the overall transcription activity of any species without designing probes for known sequences in advance. It provides accurate digital signals, higher detection throughput, and a more extensive range detection that is a powerful tool for an in-depth study of the complexity of the transcriptome.
Application Overview in the Global single cell multi omics Market
Based on the Application, the global single-cell multi-omics market classified into Oncology, Cell Biology, Neurology, Immunology, Others. The Oncology segment has dominated the demand of the worldwide single-cell multi-omics market due to rising diseases like cancer, neurology disease, cardiovascular disease. Thus, oncology helps in identifying the origin of disseminated tumor cells in the breast, brain, and any other parts in the body.
Region Overview in the Global single cell multi omics Market
Based on geography, the global single-cell multi-omics market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. The North America region is going to dominate the market growth of the single-cell multi-omics in the global market in the forecast period from 2020–2027. Owing to rising disposable income, improving healthcare infrastructure, and advance non-invasive instruments have bolstered the demand for the global single-cell multi-omics market.
Global single cell multi omics Market: Competitive Landscape
Companies such as 10x Genomics, Inc., MissionBio, 1CellBio, NanoString Technologies, Inc., Fluxion Biosciences, Fluidigm Corporation, Celsee, Inc., Bio-Rad Laboratories, Inc., BGI Genomics Co. Ltd., GE LifeSciences, Illumina, Inc., and Takara Bio, QIAGEN N.V., among others, are key players in the global single-cell multi-omics market.
Visit https://www.shingetsuresearch.com
U.S +1 217 953 4020
U.S +1(281)603–8808
[email protected]
Shingetsu Research 3309 Robbins Rd 524Springfield, IL 62704–6587.